Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|March 2, 2026
Therapeutic drug monitoring (TDM) of rituximab to predict early B-cell repopulation in children with inflammatory diseasesRana A Alsulami, Bindiya Chugani, Joley Johnstone, et al.
Pediatric Rheumatology Online Journal|May 8, 2019
Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping reviewMichelle M A Kip, Gillian Currie, Deborah A Marshall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2016
Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki DiseaseMartin Prince Alphonse, Trang T Duong, Chisato Shumitzu, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|February 2, 2010
Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006Yahui T Lin, Cedric Manlhiot, Joyce C Y Ching, et al.
Pediatric Rheumatology Online Journal|April 12, 2022
Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational studyLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
ACR Open Rheumatology|September 1, 2025
A Tale of Many Canadas: Associations of Ancestry With Juvenile Idiopathic Arthritis Categories and Disease Severity at Presentation to CareStephanie K A Wong, Lori B Tucker, Kristin Houghton, et al.
Rheumatology (Oxford, England)|May 18, 2022
Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysisMichelle M A Kip, Sytze de Roock, Gillian Currie, et al.
The Journal of Rheumatology|April 4, 2006
Corticosteroid treatment of refractory Kawasaki diseaseBianca A Lang, Rae S M Yeung, Kiem G Oen, et al.
JAMA Network Open|June 9, 2026
Acute Respiratory Tract Infections and Severe Disease Among Hospitalized ChildrenHaifa Mtaweh, Caitlyn L Kaziev, Carlee A Feinstein, et al.
MDM Policy & Practice|October 2, 2025
Development and Qualitative Evaluation of a Decision Support Tool for Withdrawal of Biologic Therapy in Nonsystemic Juvenile Idiopathic ArthritisJanine A van Til, Michelle M A Kip, Robert Marinescu-Muster, et al.
Pageof 16